Study Details
Full Title
A Phase 2a, Multicenter, Open-label, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Resmetirom in Pediatric Subjects Ages 6-17 Years with MASH with Fibrosis Stage F1-F3
Principal Investigator
Mustafa
Bashir
Protocol Number
PRO00120346
NCT ID
NA
Phase
N/A
Enrollment Status
Open to Enrollment